Atypical femur fracture in a male without history of bisphosphonate use: a case report

J Med Case Rep. 2024 Jan 4;18(1):2. doi: 10.1186/s13256-023-04308-y.

Abstract

Background: Atypical femur fractures are a rare occurrence, especially in bisphosphonate-naïve men, and merit reporting owing to their unusual presentation and clinical implications. This case report highlights a unique instance of atypical femur fractures in a 73-year-old male with no prior bisphosphonate exposure.

Case presentation: The patient, a 73-year-old Indian male with no history of bisphosphonate use, presented with left thigh pain and swelling following a minor fall. Radiographic assessment unveiled a closed left mid diaphyseal femoral shaft fracture. Subsequent imaging revealed an impending fracture in the contralateral femur. A comprehensive diagnostic evaluation, encompassing radiographic analysis, laboratory tests, and clinical assessment confirmed the diagnosis. Surgical management via intramedullary nailing was pursued for both fractures. Notably, the patient's medical history was characterized by radiographic manifestations, the infrequent occurrence of atypical femur fractures in men, and associated risk factors. Treatment encompassed anabolic bone therapy employing teriparatide, alongside discontinuation of antiresorptive agents.

Conclusions: This case underscores the significance of considering atypical femur fractures in older individuals with limited trauma history. It accentuates the role of anabolic agents in the therapeutic regimen and contributes to the evolving understanding of atypical femur fractures. The report underscores the need for vigilant monitoring and tailored management strategies in similar cases, thereby enhancing clinical practice and patient care.

Keywords: Atypical femur fractures; Bisphosphonate-naïve; Male; Surgical management; Teriparatide.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bone Density Conservation Agents* / therapeutic use
  • Diphosphonates / adverse effects
  • Femoral Fractures* / chemically induced
  • Femoral Fractures* / diagnostic imaging
  • Femoral Fractures* / surgery
  • Femur
  • Humans
  • Male
  • Teriparatide / therapeutic use

Substances

  • Diphosphonates
  • Bone Density Conservation Agents
  • Teriparatide